Investment Analysts’ New Coverage for August, 31st (ACIW, BHGE, CMTA, CORT, GEMP, GNMK, HLS, KALV, ORBK, QTNT)

Investment Analysts’ new coverage for Thursday, August 31st:

DA Davidson started coverage on shares of ACI Worldwide (NASDAQ:ACIW). DA Davidson issued a buy rating on the stock.

Barclays PLC began coverage on shares of Baker Hughes, a GE company Class A (NASDAQ:BHGE). They issued an overweight rating on the stock.

BTIG Research started coverage on shares of Clementia Pharm (NASDAQ:CMTA). They issued a buy rating and a $32.00 price target on the stock.

Stifel Nicolaus assumed coverage on shares of Corcept Therapeutics (NASDAQ:CORT). Stifel Nicolaus issued a buy rating and a $20.00 price target on the stock.

HC Wainwright began coverage on shares of Gemphire Therapeutics (NASDAQ:GEMP). The firm issued a buy rating and a $21.00 price target on the stock.

BTIG Research began coverage on shares of GenMark Diagnostics (NASDAQ:GNMK). The firm issued a buy rating and a $13.00 price target on the stock.

Stephens began coverage on shares of HealthSouth Corporation (NYSE:HLS). They issued an overweight rating on the stock.

BTIG Research initiated coverage on shares of KalVista Pharmaceuticals (NASDAQ:KALV). BTIG Research issued a buy rating and a $18.00 target price on the stock.

Stifel Nicolaus assumed coverage on shares of Orbotech (NASDAQ:ORBK). Stifel Nicolaus issued a buy rating and a $46.00 price target on the stock.

BTIG Research assumed coverage on shares of Quotient Limited (NASDAQ:QTNT). BTIG Research issued a buy rating and a $12.00 target price on the stock.

BTIG Research started coverage on shares of Veracyte (NASDAQ:VCYT). The firm issued a buy rating and a $13.00 target price on the stock.